IL138533A0 - Pharmaceutical compositions for prolonged peptide release and preparation method - Google Patents
Pharmaceutical compositions for prolonged peptide release and preparation methodInfo
- Publication number
- IL138533A0 IL138533A0 IL13853399A IL13853399A IL138533A0 IL 138533 A0 IL138533 A0 IL 138533A0 IL 13853399 A IL13853399 A IL 13853399A IL 13853399 A IL13853399 A IL 13853399A IL 138533 A0 IL138533 A0 IL 138533A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- peptide release
- prolonged
- prolonged peptide
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9803667A FR2776520B1 (fr) | 1998-03-25 | 1998-03-25 | Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
| PCT/FR1999/000667 WO1999048517A1 (fr) | 1998-03-25 | 1999-03-22 | Compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL138533A0 true IL138533A0 (en) | 2001-10-31 |
Family
ID=9524472
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13853399A IL138533A0 (en) | 1998-03-25 | 1999-03-22 | Pharmaceutical compositions for prolonged peptide release and preparation method |
| IL138533A IL138533A (en) | 1998-03-25 | 2000-09-18 | Pharmaceutical compositions comprising a peptide salt for prolonged peptide release |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL138533A IL138533A (en) | 1998-03-25 | 2000-09-18 | Pharmaceutical compositions comprising a peptide salt for prolonged peptide release |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6503534B1 (pl) |
| EP (1) | EP1066049B1 (pl) |
| JP (1) | JP4162381B2 (pl) |
| AR (1) | AR020062A1 (pl) |
| AT (1) | ATE241377T1 (pl) |
| AU (1) | AU756148B2 (pl) |
| CA (1) | CA2324901C (pl) |
| CZ (1) | CZ298941B6 (pl) |
| DE (1) | DE69908326T2 (pl) |
| DK (1) | DK1066049T3 (pl) |
| ES (1) | ES2200507T3 (pl) |
| FR (1) | FR2776520B1 (pl) |
| HU (1) | HU228903B1 (pl) |
| IL (2) | IL138533A0 (pl) |
| NO (1) | NO324621B1 (pl) |
| PL (1) | PL197775B1 (pl) |
| PT (1) | PT1066049E (pl) |
| RU (1) | RU2224538C2 (pl) |
| WO (1) | WO1999048517A1 (pl) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117057D0 (en) * | 2001-07-12 | 2001-09-05 | Ferring Bv | Pharmaceutical composition |
| RS52966B (sr) * | 2002-09-27 | 2014-02-28 | Zentaris Gmbh | Oblik za terapijsku primenu aktivnih peptida sa produženim oslobađanjem aktivnog sastojka i postupak za njihovo dobijanje |
| RU2255760C2 (ru) * | 2003-03-11 | 2005-07-10 | Общество с ограниченной ответственностью фирма "Фермент" | Средство, обладающее иммуномодулирующим, противомикробным, антиоксидантным и регенерирующим действием (варианты) |
| EP1511470A2 (en) * | 2003-03-26 | 2005-03-09 | Teva Pharmaceutical Industries Ltd. | A process for preparing a pharmaceutical active ingredient with high specific surface area |
| PT1684782E (pt) | 2003-10-03 | 2015-12-21 | Thorn Bioscience Llc | Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio |
| US7521527B2 (en) * | 2003-12-16 | 2009-04-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | GLP-1 pharmaceutical compositions |
| US20090023643A1 (en) * | 2004-01-13 | 2009-01-22 | Vasogenix Pharmaceuticals, Inc. | Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same |
| JP2007517911A (ja) * | 2004-01-13 | 2007-07-05 | バソジェニックス ファーマシューティカルズ， インコーポレイテッド | 心臓血管の適応症および腎臓の適応症に対してｃｇｒｐを使用する方法 |
| EP1703895A2 (en) * | 2004-01-13 | 2006-09-27 | Vasogenix Pharmaceuticals, Inc. | Controlled release cgrp delivery composition for cardiovascular and renal indications |
| US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
| GB0428151D0 (en) | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
| GB0511269D0 (en) * | 2005-06-02 | 2005-07-13 | Creative Peptides Sweden Ab | Sustained release preparation of pro-insulin C-peptide |
| EP1912724A2 (en) * | 2005-07-28 | 2008-04-23 | Global Research Technologies, LLC | Removal of carbon dioxide from air |
| GB0517627D0 (en) | 2005-08-30 | 2005-10-05 | Tyco Electronics Ltd Uk | Bus-bar and connector |
| US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
| US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
| CN101384272B (zh) | 2005-12-20 | 2013-05-01 | 杜克大学 | 用于递送具有增强的药理性质的活性剂的方法和组合物 |
| US20070219811A1 (en) * | 2006-03-16 | 2007-09-20 | Kim John S | Method for using an internet-based CRM application to create an on-line leads marketplace |
| CA2671925A1 (en) * | 2006-12-21 | 2008-07-10 | Stryker Corporation | Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents |
| BRPI0809441A2 (pt) * | 2007-04-04 | 2015-06-23 | Theratechnologies Inc | Formulação farmacêuticas de moléculas ghrh |
| TWI442932B (zh) * | 2008-02-11 | 2014-07-01 | Ferring Int Ct Sa | 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法 |
| EP3412300A1 (en) | 2008-06-27 | 2018-12-12 | Duke University | Therapeutic agents comprising elastin-like peptides |
| RU2568839C2 (ru) | 2009-04-23 | 2015-11-20 | ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК | Способ и композиция для синхронизации времени осеменения |
| EP2424503B1 (en) | 2009-05-01 | 2017-07-05 | Ferring BV | Composition for the treatment of prostate cancer |
| TW201043221A (en) * | 2009-05-06 | 2010-12-16 | Ferring Int Ct Sa | Kit and method for preparation of a Degarelix solution |
| US20110039787A1 (en) * | 2009-07-06 | 2011-02-17 | Ferring International Center S.A. | Compositions, kits and methods for treating benign prostate hyperplasia |
| DK3311828T3 (da) * | 2009-08-14 | 2021-06-28 | Phasebio Pharmaceuticals Inc | Modificerede vasoaktive tarmpeptider |
| MX343112B (es) * | 2010-01-13 | 2016-10-25 | Ipsen Pharma Sas | Proceso para la preparacion de composiciones farmaceuticas para la liberacion sostenida de analogos de somatostanina. |
| EP2447276A1 (en) | 2010-10-27 | 2012-05-02 | Ferring B.V. | Process for the manufacture of Degarelix and its intermediates |
| PT2632934T (pt) | 2010-10-27 | 2017-01-06 | Ferring Bv | Processo para o fabrico de degarelix e seus intermediários |
| JO3755B1 (ar) | 2011-01-26 | 2021-01-31 | Ferring Bv | تركيبات تستوستيرون |
| WO2012170524A1 (en) | 2011-06-06 | 2012-12-13 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
| DE102011114864A1 (de) | 2011-10-05 | 2013-04-11 | Acino Ag | Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat |
| SG11201407679PA (en) | 2012-06-01 | 2014-12-30 | Ferring Bv | Manufacture of degarelix |
| DK2925339T3 (da) | 2012-11-28 | 2020-07-20 | United Ah Ii Llc | Fremgangsmåde til synkronisering af inseminationstidspunkt hos gylte |
| EP2823808A1 (en) | 2013-07-09 | 2015-01-14 | Ipsen Pharma S.A.S. | Pharmaceutical composition for a sustained release of lanreotide |
| TW201605488A (zh) | 2013-10-15 | 2016-02-16 | 大塚製藥股份有限公司 | 用以預防及／或治療多囊腎病之藥物 |
| EP2910255A1 (en) * | 2014-02-19 | 2015-08-26 | MedSkin Solutions Dr. Suwelack AG | Methods for the production of biopolymers with defined average molecular weight |
| TW201625218A (zh) * | 2014-04-18 | 2016-07-16 | Ｊｂｓ聯合動物保健有限責任公司 | 製造含ｇｎｒｈ凝膠之方法 |
| WO2015172046A1 (en) | 2014-05-08 | 2015-11-12 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating cystic fibrosis |
| CA2976038A1 (en) | 2015-02-09 | 2016-08-18 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating muscle disease and disorders |
| WO2020170185A1 (en) * | 2019-02-21 | 2020-08-27 | Dr. Reddy’S Laboratories Limited | Substantially pure lanreotide or its salt & process thereof |
| GR1009814B (el) * | 2019-07-29 | 2020-09-11 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδιο αναλογο σωματοστατινης |
| CN110577567A (zh) * | 2019-09-03 | 2019-12-17 | 杭州诺泰澳赛诺医药技术开发有限公司 | 一种制备高比表面积活性多肽或蛋白的方法 |
| CN118302211A (zh) * | 2021-11-22 | 2024-07-05 | Specgx有限责任公司 | 可注射缓释药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0739339B2 (ja) * | 1989-05-01 | 1995-05-01 | アルカーメス コントロールド セラピューティクス，インコーポレイテッド | 生物活性を有する分子の小粒子の製造方法 |
| JP3100005B2 (ja) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | ヒト免疫不全ウィルス感染・増殖抑制剤 |
| US5595760A (en) * | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
-
1998
- 1998-03-25 FR FR9803667A patent/FR2776520B1/fr not_active Expired - Lifetime
-
1999
- 1999-03-22 PT PT99910418T patent/PT1066049E/pt unknown
- 1999-03-22 CA CA2324901A patent/CA2324901C/fr not_active Expired - Lifetime
- 1999-03-22 WO PCT/FR1999/000667 patent/WO1999048517A1/fr not_active Ceased
- 1999-03-22 IL IL13853399A patent/IL138533A0/xx active IP Right Grant
- 1999-03-22 ES ES99910418T patent/ES2200507T3/es not_active Expired - Lifetime
- 1999-03-22 AT AT99910418T patent/ATE241377T1/de active
- 1999-03-22 AU AU29384/99A patent/AU756148B2/en not_active Expired
- 1999-03-22 DK DK99910418T patent/DK1066049T3/da active
- 1999-03-22 CZ CZ20003432A patent/CZ298941B6/cs not_active IP Right Cessation
- 1999-03-22 JP JP2000537564A patent/JP4162381B2/ja not_active Expired - Lifetime
- 1999-03-22 RU RU2000126755/15A patent/RU2224538C2/ru active
- 1999-03-22 PL PL343005A patent/PL197775B1/pl unknown
- 1999-03-22 HU HU0101545A patent/HU228903B1/hu unknown
- 1999-03-22 EP EP99910418A patent/EP1066049B1/fr not_active Expired - Lifetime
- 1999-03-22 DE DE69908326T patent/DE69908326T2/de not_active Expired - Lifetime
- 1999-03-22 US US09/646,519 patent/US6503534B1/en not_active Expired - Lifetime
- 1999-03-23 AR ARP990101275A patent/AR020062A1/es not_active Application Discontinuation
-
2000
- 2000-09-18 IL IL138533A patent/IL138533A/en not_active IP Right Cessation
- 2000-09-22 NO NO20004741A patent/NO324621B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20003432A3 (cs) | 2001-02-14 |
| ES2200507T3 (es) | 2004-03-01 |
| DE69908326D1 (de) | 2003-07-03 |
| PT1066049E (pt) | 2003-10-31 |
| AU756148B2 (en) | 2003-01-02 |
| IL138533A (en) | 2006-12-31 |
| JP2002507578A (ja) | 2002-03-12 |
| RU2224538C2 (ru) | 2004-02-27 |
| PL343005A1 (en) | 2001-07-30 |
| FR2776520A1 (fr) | 1999-10-01 |
| AR020062A1 (es) | 2002-04-10 |
| EP1066049A1 (fr) | 2001-01-10 |
| NO324621B1 (no) | 2007-11-26 |
| CZ298941B6 (cs) | 2008-03-19 |
| AU2938499A (en) | 1999-10-18 |
| EP1066049B1 (fr) | 2003-05-28 |
| DK1066049T3 (da) | 2003-09-29 |
| DE69908326T2 (de) | 2004-03-25 |
| WO1999048517A1 (fr) | 1999-09-30 |
| NO20004741L (no) | 2000-11-22 |
| HUP0101545A3 (en) | 2001-12-28 |
| CA2324901C (fr) | 2012-01-24 |
| ATE241377T1 (de) | 2003-06-15 |
| HUP0101545A1 (hu) | 2001-11-28 |
| CA2324901A1 (fr) | 1999-09-30 |
| HU228903B1 (en) | 2013-06-28 |
| FR2776520B1 (fr) | 2000-05-05 |
| NO20004741D0 (no) | 2000-09-22 |
| PL197775B1 (pl) | 2008-04-30 |
| JP4162381B2 (ja) | 2008-10-08 |
| US6503534B1 (en) | 2003-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL343005A1 (en) | Pharmaceutical compositions for prolonged peptide release and preparation method | |
| IL123986A0 (en) | Antithombotic agents process for their preparation and pharmaceutical compositions comprising them | |
| HUP0203374A3 (en) | Sold oral pharmaceutical composition and process for its preparation | |
| IL136938A0 (en) | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
| IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
| HU9800985D0 (en) | Retarde polymere compositions for pharmaceutical compositions | |
| HUP0004400A3 (en) | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| CZ20011518A3 (cs) | Farmaceutický prostředek | |
| HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
| SG79255A1 (en) | Pharmaceutical formulations | |
| HUP0104762A3 (en) | Pharmaceutical moxifloxacin compositions and process for their preparation | |
| HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
| AU2091499A (en) | Permeable compositions and methods for their preparation | |
| HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
| PT1466615E (pt) | Composição farmacêutica | |
| HUP0102515A3 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
| PL343769A1 (en) | Pharmaceutical composition | |
| IL123927A (en) | Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them | |
| HUP0104985A3 (en) | Pharmaceutical levothyroxine compositions and process for their preparation | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| AP2001002371A0 (en) | Streptogramin derivatives preparation and compositions containing them | |
| EG24463A (en) | Modified release pharmaceutical composition | |
| EP1127860A4 (en) | PYROTECHNIC COMPOSITION AND METHOD FOR MANUFACTURING THE SAME | |
| HUP0101098A3 (en) | Streptogramin derivatives, process for preparation thereof and compositions containing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |